You are currently viewing a new version of our website. To view the old version click .

Pharmaceutics, Volume 15, Issue 7

July 2023 - 235 articles

Cover Story: In oral absorption, dissolution limitations can occur if the time required for dissolution is longer than the small intestinal transit time and/or if dissolution is slower than the drug’s permeation through the gut wall. A standard method for overcoming dissolution issues is to reduce the particle size of the (solid) drug. Building on the refined Developability Classification System (rDCS), this work establishes a novel set of equations with which the degree of particle size reduction needed to mitigate dissolution limitations can be calculated. According to the type of data available, the appropriate equation(s) for each situation can be applied. Three example drugs, representing a wide range of physicochemical characteristics, are used to illustrate the implementation of the equations: voriconazole, lemborexant and istradefylline. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (235)

  • Article
  • Open Access
7 Citations
2,314 Views
20 Pages

Dual-Ligand Synergistic Targeting Anti-Tumor Nanoplatforms with Cascade-Responsive Drug Release

  • Fang Luo,
  • Ting Zhong,
  • Ying Chen,
  • Qianqian Guo,
  • Ling Tao,
  • Xiangchun Shen,
  • Yanhua Fan and
  • Xingjie Wu

Dual-ligand targeting drug delivery nanoplatforms are considered a promising tool for enhancing the specificity of chemotherapy. However, serious off-target delivery has been observed in current dual-ligand targeting nanoplatforms, as each ligand can...

  • Review
  • Open Access
8 Citations
2,828 Views
34 Pages

COST Action CA17140 Cancer Nanomedicine—from the bench to the bedside (Nano2Clinic,) is the first, pan-European interdisciplinary network of representatives from academic institutions and small and medium enterprises including clinical research...

  • Article
  • Open Access
4 Citations
2,071 Views
18 Pages

A Moexitecan Magnetic Liposomal Strategy for Ferroptosis-Enhanced Chemotherapy

  • Weiling Miao,
  • Yang Liu,
  • Jian Tang,
  • Tiandong Chen and
  • Fang Yang

Moexitecan (Mex) is a novel camptothecin derivative that retains the potent antitumor properties of camptothecin drugs and has improved hydrophilicity to enhance biocompatibility in vitro. However, single-drug therapy still has limitations. In this s...

  • Review
  • Open Access
18 Citations
3,401 Views
25 Pages

Bio-Inspired Nanocarriers Derived from Stem Cells and Their Extracellular Vesicles for Targeted Drug Delivery

  • Munire Abudurexiti,
  • Yue Zhao,
  • Xiaoling Wang,
  • Lu Han,
  • Tianqing Liu,
  • Chengwei Wang and
  • Zhixiang Yuan

With their seemingly limitless capacity for self-improvement, stem cells have a wide range of potential uses in the medical field. Stem-cell-secreted extracellular vesicles (EVs), as paracrine components of stem cells, are natural nanoscale particles...

  • Article
  • Open Access
11 Citations
3,470 Views
13 Pages

Sodium Alginate/Chitosan-Coated Liposomes for Oral Delivery of Hydroxy-α-Sanshool: In Vitro and In Vivo Evaluation

  • Fengming Tan,
  • Huan Li,
  • Kai Zhang,
  • Lulu Xu,
  • Dahan Zhang,
  • Yang Han and
  • Jing Han

Background: Hydroxy-α-Sanshool (HAS) possesses various pharmacological properties, such as analgesia and regulating gastrointestinal function. However, the low oral bioavailability of HAS has limited its oral delivery in clinical application. M...

  • Article
  • Open Access
3 Citations
1,953 Views
17 Pages

Among potential macromolecule-based pharmaceuticals, polycations seem particularly interesting due to their proven antimicrobial properties and use as vectors in gene therapy. This makes an understanding of the mechanisms of these molecules’ in...

  • Article
  • Open Access
6 Citations
2,518 Views
13 Pages

Curcumin–Triterpene Type Hybrid as Effective Sonosensitizers for Sonodynamic Therapy in Oral Squamous Cell Carcinoma

  • Katarzyna Sowa-Kasprzak,
  • Małgorzata Józkowiak,
  • Dorota Olender,
  • Anna Pawełczyk,
  • Hanna Piotrowska-Kempisty and
  • Lucjusz Zaprutko

Sonodynamic therapy (SDT) is a non-invasive therapeutic modality in cancer treatment that combines low-intensity ultrasound (US) and sonosensitizers. Tumor cells are destroyed through the synergistic effects of ultrasound and a chemical sonosensitize...

  • Article
  • Open Access
5 Citations
2,400 Views
22 Pages

An In Vivo Electroencephalographic Analysis of the Effect of Riluzole against Limbic and Absence Seizure and Comparison with Glutamate Antagonists

  • Rita Citraro,
  • Francesca Bosco,
  • Gianfranco Di Gennaro,
  • Martina Tallarico,
  • Lorenza Guarnieri,
  • Luca Gallelli,
  • Vincenzo Rania,
  • Antonio Siniscalchi,
  • Giovambattista De Sarro and
  • Antonio Leo

Background: Riluzole (RLZ) has demonstrated neuroprotective effects in several neurological disorders. These neuroprotective effects seem to be mainly due to its ability to inhibit the excitatory glutamatergic neurotransmission, acting on different t...

  • Article
  • Open Access
4 Citations
4,821 Views
17 Pages

Preparation and Evaluation of Auxiliary Permeable Microneedle Patch Composed of Polyvinyl Alcohol and Eudragit NM30D Aqueous Dispersion

  • Mengzhen Xing,
  • Yuning Ma,
  • Xiaocen Wei,
  • Chen Chen,
  • Xueli Peng,
  • Yuxia Ma,
  • Bingwen Liang,
  • Yunhua Gao and
  • Jibiao Wu

Poor transdermal permeability limits the possibility of most drug delivery through the skin. Auxiliary permeable microneedles (AP-MNs) with a three-dimensional network structure can effectively break the skin stratum corneum barrier and assist in the...

  • Review
  • Open Access
23 Citations
5,312 Views
32 Pages

Next-Generation Nanomedicine Approaches for the Management of Retinal Diseases

  • Binapani Mahaling,
  • Shermaine W. Y. Low,
  • Sanjay Ch,
  • Utkarsh R. Addi,
  • Baseer Ahmad,
  • Thomas B. Connor,
  • Rajiv R. Mohan,
  • Swati Biswas and
  • Shyam S. Chaurasia

Retinal diseases are one of the leading causes of blindness globally. The mainstay treatments for these blinding diseases are laser photocoagulation, vitrectomy, and repeated intravitreal injections of anti-vascular endothelial growth factor (VEGF) o...

of 24

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceutics - ISSN 1999-4923Creative Common CC BY license